Hi friend,

Aisel, Lissun, Ours Privacy and Lean Therapeutics all raised funding rounds this week.

Limbic became the first mental health company selected for the FDA's TEMPO pilot, with their newly announced product “Unpacked”. Just today, SonderMind joined them, with their smartphone-based SonderMind Adjunctive Care Application (SACA) also accepted into TEMPO.

There is a new scoping review in Nature digital medicine on the mental health harms of LLM-based chatbots, new research on the impact of semaglutide use for people living with psychiatric conditions, and The Path published a small study examining engagement with its AI chatbot, Mental.

Let’s get into it!